Morning Briefing
Summaries of health policy coverage from major news organizations
Scientists Find Single Dose Of Drug Cures Visceral Leishmaniasis
Scientists have discovered that a single infusion of Gilead Sciences' drug AmBisome, known generically as iposomal amphotericin B, cures patients with the visceral leishmaniasis, or kala-azar, a parasitic infection, Reuters reports. Spread by the sand fly and affecting 500,000 people a year, visceral leishmaniasis is found in Asia, Africa, and parts of Europe, but is concentrated in India, according to the news service.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
